Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Trachtenberg

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Urology|May 1, 1987
Ketoconazole therapy in advanced prostatic cancerJ Trachtenberg
The Journal of Urology|June 1, 1983
The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogueJ Trachtenberg
The Journal of Urology|July 1, 1997
Androgen ablation therapy--where to next?J Trachtenberg
Discharge Planning Update|December 9, 1992
Issues for patient and familyJ Trachtenberg
The Journal of Urology|September 1, 1984
The effects of ketoconazole on testosterone production and normal and malignant androgen dependent tissues of the adult ratJ Trachtenberg
The Journal of Urology|November 1, 1982
The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostateJ Trachtenberg
European Urology|January 1, 1996
Healthcare resources should be targeted to chemoprevention: the argument againstJ Trachtenberg
The Journal of Urology|April 1, 1987
Experimental treatment of prostatic cancer by intermittent hormonal therapyJ Trachtenberg
European Urology|January 1, 1997
Innovative approaches to the hormonal treatment of advanced prostate cancerJ Trachtenberg
Discharge Planning Update|October 5, 1993
Health care reform. Examining the options for practiceJ Trachtenberg
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Urology|May 1, 1987
Ketoconazole therapy in advanced prostatic cancerJ Trachtenberg
The Journal of Urology|June 1, 1983
The treatment of metastatic prostatic cancer with a potent luteinizing hormone releasing hormone analogueJ Trachtenberg
The Journal of Urology|July 1, 1997
Androgen ablation therapy--where to next?J Trachtenberg
Discharge Planning Update|December 9, 1992
Issues for patient and familyJ Trachtenberg
The Journal of Urology|September 1, 1984
The effects of ketoconazole on testosterone production and normal and malignant androgen dependent tissues of the adult ratJ Trachtenberg
The Journal of Urology|November 1, 1982
The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostateJ Trachtenberg
European Urology|January 1, 1996
Healthcare resources should be targeted to chemoprevention: the argument againstJ Trachtenberg
The Journal of Urology|April 1, 1987
Experimental treatment of prostatic cancer by intermittent hormonal therapyJ Trachtenberg
European Urology|January 1, 1997
Innovative approaches to the hormonal treatment of advanced prostate cancerJ Trachtenberg
Discharge Planning Update|October 5, 1993
Health care reform. Examining the options for practiceJ Trachtenberg
Pageof 15